Brief: Allovir Announces $126.6 Mln Registered Direct Offering
July 27 (Reuters) - Allovir Inc ALVR.O :
* ALLOVIR ANNOUNCES $126.6 MILLION REGISTERED DIRECT
OFFERING
* ALLOVIR - ENTERED INTO SECURITIES PURCHASE AGREEMENT TO
SELL
27.5 MILLION SHARES OF COMMON STOCK IN REGISTERED DIRECT
OFFERING AT $4.61 PER SHARE
* ALLOVIR INC - PROCEEDS SUPPORT COMPLETION OF THREE GLOBAL
PHASE
3 REGISTRATIONAL TRIALS FOR POSOLEUCEL AND GLOBAL REGULATORY
FILINGS
Source text for Eikon: ID:nBw5WXTJ7a
Further company coverage: ALVR.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Kalaris Therapeutics
See all newsKalaris Therapeutics Inc reports results for the quarter ended June 30 - Earnings Summary
Kalaris Therapeutics Q2 net loss narrows on lower administrative costs
Kalaris Therapeutics Inc expected to post a loss of 49 cents a share - Earnings Preview
Kalaris Therapeutics posts smaller-than-expected Q1 net loss
Brief: Kalaris Therapeutics Inc Q1 Operating Income USD -11.833 Million